Clinical Trials Directory

Trials / Unknown

UnknownNCT02005809

Clinical Impact of Second-look Endoscopy After Endoscopic Submucosal Dissection of Gastric Neoplasm

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
268 (estimated)
Sponsor
Kosin University Gospel Hospital · Academic / Other
Sex
All
Age
20 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Gastroenterologists often follow up second look endoscopy after endoscopic submucosal dissection(ESD) of gastric neoplasms because they want to prevent bleeding of procedure sites. But Goto suggested in his retrospective analysis that a second-look endoscopy after endoscopic submucosal dissection for gastric epithelial neoplasm may be unnecessary. So, the investigators try to identify the hypothesis prospectively in this study.

Conditions

Interventions

TypeNameDescription
PROCEDUREsecond look endoscopySecond look endoscopy includes observation or prophylactic bleeding control of ESD site.

Timeline

Start date
2013-03-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2013-12-09
Last updated
2013-12-09

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02005809. Inclusion in this directory is not an endorsement.

Clinical Impact of Second-look Endoscopy After Endoscopic Submucosal Dissection of Gastric Neoplasm (NCT02005809) · Clinical Trials Directory